Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice

BACKGROUND: Alzheimer's disease (AD) brain shows an ongoing inflammatory condition and non-steroidal anti-inflammatories diminish the risk of suffering the neurologic disease. Cannabinoids are neuroprotective and anti-inflammatory agents with therapeutic potential. METHODS: We have studied the...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Moreno, Ana María, Brera, Begoña, Spuch, Carlos, Carro, Eva, García-García, Luis, Delgado, Mercedes, Pozo, Miguel A, Innamorato, Nadia G, Cuadrado, Antonio, de Ceballos, María L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292807/
https://www.ncbi.nlm.nih.gov/pubmed/22248049
http://dx.doi.org/10.1186/1742-2094-9-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292807/
https://www.ncbi.nlm.nih.gov/pubmed/22248049
http://dx.doi.org/10.1186/1742-2094-9-8

Ejemplares similares